65 related articles for article (PubMed ID: 31187490)
1. ALDH1A1 in patient-derived bladder cancer spheroids activates retinoic acid signaling leading to TUBB3 overexpression and tumor progression.
Namekawa T; Ikeda K; Horie-Inoue K; Suzuki T; Okamoto K; Ichikawa T; Yano A; Kawakami S; Inoue S
Int J Cancer; 2020 Feb; 146(4):1099-1113. PubMed ID: 31187490
[TBL] [Abstract][Full Text] [Related]
2. Impact of the thyroid hormone T3 and its nuclear receptor TRα1 on colon cancer stem cell phenotypes and response to chemotherapies.
Giolito MV; Bodoirat S; La Rosa T; Reslinger M; Guardia GDA; Mourtada J; Claret L; Joung A; Galante PAF; Penalva LOF; Plateroti M
Cell Death Dis; 2024 May; 15(5):306. PubMed ID: 38693105
[TBL] [Abstract][Full Text] [Related]
3. NFκB Promotes Ovarian Tumorigenesis via Classical Pathways That Support Proliferative Cancer Cells and Alternative Pathways That Support ALDH
House CD; Jordan E; Hernandez L; Ozaki M; James JM; Kim M; Kruhlak MJ; Batchelor E; Elloumi F; Cam MC; Annunziata CM
Cancer Res; 2017 Dec; 77(24):6927-6940. PubMed ID: 29074539
[TBL] [Abstract][Full Text] [Related]
4. A Novel ALDH1A1 Inhibitor Blocks Platinum-Induced Senescence and Stemness in Ovarian Cancer.
Muralikrishnan V; Fang F; Given TC; Podicheti R; Chtcherbinine M; Metcalfe TX; Sriramkumar S; O'Hagan HM; Hurley TD; Nephew KP
Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884498
[TBL] [Abstract][Full Text] [Related]
5. GRIK2 is a target for bladder cancer stem-like cell-targeting immunotherapy.
Miyata H; Hirohashi Y; Yamada S; Yanagawa J; Murai A; Hashimoto S; Tokita S; Hori K; Abe T; Kubo T; Tsukahara T; Kanaseki T; Shinohara N; Torigoe T
Cancer Immunol Immunother; 2022 Apr; 71(4):795-806. PubMed ID: 34405274
[TBL] [Abstract][Full Text] [Related]
6. β-Tubulin Isotype, TUBB4B, Regulates The Maintenance of Cancer Stem Cells.
Dharmapal D; Jyothy A; Mohan A; Balagopal PG; George NA; Sebastian P; Maliekal TT; Sengupta S
Front Oncol; 2021; 11():788024. PubMed ID: 35004310
[TBL] [Abstract][Full Text] [Related]
7. Synergistic eradicating impact of 5-fluouracil with FeO nanoparticles-diethyldithiocarbamate in colon cancer spheroids.
Abu-Serie MM
Nanomedicine (Lond); 2024 Apr; ():. PubMed ID: 38578787
[No Abstract] [Full Text] [Related]
8. Stemness and Cell Cycle Regulators and Their Modulation by Retinoic Acid in Ewing Sarcoma.
Battistella ME; Freire NH; Toson B; Dalmolin M; Fernandes MAC; Tassinari ID; Jaeger M; Brunetto AT; Brunetto AL; Gregianin L; de Farias CB; Roesler R
Curr Issues Mol Biol; 2024 Apr; 46(5):3990-4003. PubMed ID: 38785514
[TBL] [Abstract][Full Text] [Related]
9. HIF1α inhibitor 2-methoxyestradiol decreases NRN1 expression and represses in vivo and in vitro growth of patient-derived testicular germ cell tumor spheroids.
Namekawa T; Kitayama S; Ikeda K; Horie-Inoue K; Suzuki T; Okamoto K; Ichikawa T; Yano A; Kawakami S; Inoue S
Cancer Lett; 2020 Oct; 489():79-86. PubMed ID: 32544513
[TBL] [Abstract][Full Text] [Related]
10. Omeprazole as a potent activator of human cytosolic aldehyde dehydrogenase ALDH1A1.
Calleja LF; Belmont-Díaz JA; Medina-Contreras O; Quezada H; Yoval-Sánchez B; Campos-García J; Rodríguez-Zavala JS
Biochim Biophys Acta Gen Subj; 2020 Jan; 1864(1):129451. PubMed ID: 31678145
[TBL] [Abstract][Full Text] [Related]
11. 3D Tumor Models and Their Use for the Testing of Immunotherapies.
Boucherit N; Gorvel L; Olive D
Front Immunol; 2020; 11():603640. PubMed ID: 33362787
[TBL] [Abstract][Full Text] [Related]
12. Emerging Roles of Cancer Stem Cells in Bladder Cancer Progression, Tumorigenesis, and Resistance to Chemotherapy: A Potential Therapeutic Target for Bladder Cancer.
Abugomaa A; Elbadawy M; Yamawaki H; Usui T; Sasaki K
Cells; 2020 Jan; 9(1):. PubMed ID: 31963556
[TBL] [Abstract][Full Text] [Related]
13. ALDH1: A potential therapeutic target for cancer stem cells in solid tumors.
Wei Y; Li Y; Chen Y; Liu P; Huang S; Zhang Y; Sun Y; Wu Z; Hu M; Wu Q; Wu H; Liu F; She T; Ning Z
Front Oncol; 2022; 12():1026278. PubMed ID: 36387165
[TBL] [Abstract][Full Text] [Related]
14. Aldehyde dehydrogenase 1A1 and 1A3 isoforms - mechanism of activation and regulation in cancer.
Poturnajova M; Kozovska Z; Matuskova M
Cell Signal; 2021 Nov; 87():110120. PubMed ID: 34428540
[TBL] [Abstract][Full Text] [Related]
15. Targeted therapies in bladder cancer: signaling pathways, applications, and challenges.
Peng M; Chu X; Peng Y; Li D; Zhang Z; Wang W; Zhou X; Xiao D; Yang X
MedComm (2020); 2023 Dec; 4(6):e455. PubMed ID: 38107059
[TBL] [Abstract][Full Text] [Related]
16. Modification of lysine-260 2-hydroxyisobutyrylation destabilizes ALDH1A1 expression to regulate bladder cancer progression.
Zhang Z; Wang Y; Liang Z; Meng Z; Zhang X; Ma G; Chen Y; Zhang M; Su Y; Li Z; Liang Y; Niu H
iScience; 2023 Nov; 26(11):108142. PubMed ID: 37867947
[TBL] [Abstract][Full Text] [Related]
17. Targeting the retinoic acid signaling pathway as a modern precision therapy against cancers.
Lavudi K; Nuguri SM; Olverson Z; Dhanabalan AK; Patnaik S; Kokkanti RR
Front Cell Dev Biol; 2023; 11():1254612. PubMed ID: 37645246
[TBL] [Abstract][Full Text] [Related]
18. ALDH1A1 promotes PARP inhibitor resistance by enhancing retinoic acid receptor-mediated DNA polymerase θ expression.
Lavudi K; Banerjee A; Li N; Yang Y; Cai S; Bai X; Zhang X; Li A; Wani E; Yang SM; Zhang J; Rai G; Backes F; Patnaik S; Guo P; Wang QE
NPJ Precis Oncol; 2023 Jul; 7(1):66. PubMed ID: 37429899
[TBL] [Abstract][Full Text] [Related]
19. A Novel Immune-Related Signature to Predict Prognosis and Immune Infiltration of Cervical Cancer.
Lin Y; Zhang R; Pan H; Li Y
Med Sci Monit; 2023 Mar; 29():e938660. PubMed ID: 36973995
[TBL] [Abstract][Full Text] [Related]
20. Aldehyde dehydrogenase in solid tumors and other diseases: Potential biomarkers and therapeutic targets.
Xia J; Li S; Liu S; Zhang L
MedComm (2020); 2023 Feb; 4(1):e195. PubMed ID: 36694633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
